Month: March 2020

EDMONTON, Alberta, March 23, 2020 (GLOBE NEWSWIRE) — Visionstate Corp. (TSX-V: VIS) (“Visionstate” or “the Company”) is pleased to announce it has shipped its first Internet of Things (IoT) buttons to hospitals in Vancouver, BC, marking the initial deployment of the new technology developed by the Company.The buttons, called Wanda QuickTouch, were developed to address the need for rapid deployment in a facility of any size. The IoT buttons send instant alerts to management advising of any cleaning or maintenance issues that may pose risks to the public safety. The technology enables facility managers to track alerts and staff response times, as well as monitor regular cleaning activities in the high-traffic areas.“COVID-19 has demonstrated the need for facilities to be proactive on cleaning issues,” explains John Putters, CEO of...

S. Louise Phanstiel Appointed Chair of the Board of Directors; John T. Henderson, M.D., to Remain on the BoardSALT LAKE CITY, March 23, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and precision medicine, announced today that S. Louise Phanstiel has been appointed as chair of the Board of Directors.  John T. Henderson, M.D., will remain on the Board of Directors.“I would like to thank John for his numerous contributions to Myriad as chair of the board.  Under his tenure, Myriad has undergone dramatic diversification and growth,” said S. Louise Phanstiel, chair of the Board of Directors at Myriad Genetics. “I look forward to working with the board and management team at Myriad Genetics to ensure we maintain our global leadership in precision medicine.”“This change in the leadership...

– Phase 1 Healthy Volunteers Study Expected to Begin in Mid-Year 2020 –CAMBRIDGE, Mass., March 23, 2020 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s investigational new drug (IND) application for AG-946, a next-generation pyruvate kinase-R (PKR) activator. FDA has completed its 30-day safety review and granted approval to proceed with the proposed Phase 1 healthy volunteers study.“As our eighth IND in just 10 years, AG-946 demonstrates the consistent productivity of our research engine and our leadership in the understanding of PKR activation,” said Bruce Car, Ph.D., chief scientific officer at Agios. “By advancing AG-946 into the clinic, we have the opportunity to expand our PKR activation program and build on the expertise...

REDWOOD CITY, Calif., March 23, 2020 (GLOBE NEWSWIRE) — Codexis, Inc., a leading protein engineering company and developer of novel biotherapeutics, announces the signing of a strategic collaboration and license agreement with Takeda Pharmaceutical Company Limited (Takeda) for the research and development of novel gene therapies for certain disease indications, including the treatment of lysosomal storage disorders and blood factor deficiencies.Under the terms of the agreement, Codexis will generate novel gene sequences encoding protein variants tailored to enhance efficacy as a result of increased activity, stability, and cellular uptake using its CodeEvolver® protein engineering platform. Takeda will combine these improved transgenes with its gene therapy capabilities to generate novel candidates for the treatment of rare genetic...

LONDON, March 23, 2020 (GLOBE NEWSWIRE) — Midpoint Holdings Limited (TSXV: MPT) (Frankfurt: 8MH1) (“Midpoint” or the “Company”) advises that, in an effort to mitigate and minimize any health related risks to its personnel, it has instituted various measures in response to the global COVID-19 pandemic outbreak. The Company is doing everything it can to support our staff and customers at this challenging time and would like to reassure shareholders that it is business as usual at Midpoint. The advent of technological upgrades allows for high levels of efficiency and operational continuity in situations where employees choose to work remotely.   As a result, Midpoint advises that it does not expect any disruption in providing its service offerings whatsoever. “In the digital age, the utilization of paper currency to conduct commerce...

NEWS ANNOUNCEMENT                                       FOR IMMEDIATE RELEASE

MONTREAL, March 23, 2020 (GLOBE NEWSWIRE) — Stingray Group Inc (TSX: RAY.A; RAY.B) (“Stingray”), a leading music, media and technology company, today announced that it has received approval of the Toronto Stock Exchange (“TSX”) to amend its normal course issuer bid (“NCIB”) in order to increase the maximum number of subordinate voting shares and variable subordinate voting shares (collectively, “Subordinate Shares”) that it intends to repurchase for cancellation during the twelve month period ending August 15, 2020 from 2,924,220 Subordinate Shares to 4,903,887 Subordinate Shares, representing approximately 10% of the public float of Subordinate Voting Shares as at August 7, 2019. All other terms and conditions of the NCIB remain unchanged.The Subordinate Shares will be purchased on behalf of Stingray by a registered broker through...

MONTRÉAL, 23 mars 2020 (GLOBE NEWSWIRE) — Groupe Stingray Inc. (TSX : RAY.A; RAY.B) (« Stingray »), chef de file dans les domaines de la musique, des médias et de la technologie, a annoncé aujourd’hui qu’il avait obtenu de la Bourse de Toronto (la « TSX ») l’autorisation de modifier son offre publique de rachat dans le cours normal des activités (l’« offre de rachat ») afin d’augmenter le nombre maximal d’actions à droit de vote subalterne et d’actions à droit de vote subalterne variable (collectivement, les « actions à droit de vote subalterne ») qu’il a l’intention de racheter aux fins d’annulation au cours de la période de 12 mois se terminant le 15 août 2020, pour le faire passer de 2 924 220 à 4 903 887 actions à droit de vote subalterne, ce qui représente environ 10 % du flottant des actions à droit de vote subalterne au 7 août...

Hod Hasharon, Israel, March 23, 2020 (GLOBE NEWSWIRE) — Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT), a leading global provider of innovative network intelligence and security-as-a-service (SECaaS) solutions for communication service providers and enterprises, today announced that it was chosen by Broadcom as the recommended vendor to offer a transition path from the discontinued PacketShaper line of products to the Allot Secure Service Gateway (SSG). ###Additional Resources:Allot Blog: https://www.allot.com/blogFollow us on Twitter: @allot_ltdFollow us on LinkedIn: https://www.linkedin.com/company/allot-communications About AllotAllot Ltd. (NASDAQ: ALLT, TASE: ALLT) is a provider of leading innovative network intelligence and security solutions for service providers and enterprises worldwide, enhancing value to their customers. Our solutions...

BROOKFIELD NEWS, March 23, 2020 (GLOBE NEWSWIRE) — Brookfield Asset Management Inc. (TSX: BAM.A, NYSE: BAM) today released an Update for Brookfield Shareholders, which can be accessed at: https://bam.brookfield.com/~/media/Files/B/Brookfield-BAM-IR-V2/documents/ Update_for_Brookfield_Shareholders_3-23-2020.pdfBrookfield Asset Management Inc. is a leading global alternative asset manager with over $540 billion of assets under management across real estate, infrastructure, renewable power, private equity and credit. Brookfield owns and operates long-life assets and businesses, many of which form the backbone of the global economy. Utilizing its global reach, access to large-scale capital and operational expertise, Brookfield offers a range of alternative investment products to investors around the world—including public and private...